Real-time insights. Smarter decisions. Better trades.
π Search Stocks 14 day Free Trial
CLINUVEL PHARMACEUTICALS LIMITED (CUV)ASX AI Signals has generated 2 signal(s) for CUV during the last 90 days, indicating Moderate trading activity
Latest CUV Signals | |
| 04/06/2026 | π PRO |
| 08/04/2026 | π PRO |
CLINUVEL PHARMACEUTICALS LIMITED(CUV) Share Price | |
| Current Price | $10.050 |
| 52 Week High | $13.634 |
| 52 Week Low: | $8.720 |
| Trading at (% of 52 Week High) | 73.71% |
Clinuvel Pharmaceuticals Limited (ASX: CUV) is a biopharmaceutical company that develops treatments for patients with rare genetic and skin disorders. The company specializes in photomedicine, focusing on therapies that improve the skinβs ability to repair damage caused by ultraviolet radiation. Its lead product is approved for the treatment of a rare condition called erythropoietic protoporphyria (EPP).
The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.
π Upgrade to PRO to reveal this signal
As the Australian market grapples with a challenging start to the week, influenced by global economic jitters and a dip in US indices, investors are closely watching how these conditions might impact high-growth sectors. In such an environment, identifying tech stocks with robust innovation and adap
As the Australian market navigates a soft week with the ASX200 down approximately 2%, local investors are looking to the bullish sentiment from Wall Street, which has recently set new record highs despite global geopolitical tensions. In this climate, identifying high growth tech stocks in Australia
As Australian shares experience a mixed start to the week, diverging from Wall Street's recent rallies, investors are closely monitoring global events such as tensions in the Strait of Hormuz and fluctuations in Brent crude prices. In this dynamic environment, identifying high growth tech stocks in
As Australian shares anticipate a +0.5% advance, driven by optimism surrounding geopolitical developments in the Middle East and a return to market normalcy, investors are keenly observing how these factors influence equities and commodities. In this environment, growth companies with high insider o
As of October 2025, the Australian market has shown resilience with the S&P/ASX 200 index climbing past the 9,000-point mark despite mixed economic signals such as weak jobs data and stronger-than-expected inflation. In this dynamic environment, identifying high-growth tech stocks requires careful c
Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.
14 Day Free Trial β’ Cancel Anytime β’ Founders Price $15/month
Start My Free Trial